DX-2240 is a human monoclonal antibody (mAb) that targets TIE1. It can inhibit tumor growth and render the tumor vasculature sensitive to anti-angiogenic agents (VEGF pathway inhibitors).
Target:
Tie-2
* VAT and and shipping costs not included. Errors and price changes excepted
